FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3038823489> ?p ?o ?g. }

• W3038823489 endingPage "1439" @default.
• W3038823489 startingPage "1438" @default.
• W3038823489 abstract "Telemedicine and e-HealthVol. 26, No. 12 Letter to the EditorFree AccessLetter to the Editor: Support Through Social Networks of e-Health in Adults with Primary Immunodeficiencies During COVID-19 PandemicVictor Matheu, Ruperto González-Pérez, Paloma Poza-Guedes, Cristina Álava-Cruz, Elena Mederos Luís, Inmaculada Sánchez-Machín, Andres Franco, and Yvelise BarriosVictor MatheuAddress correspondence to: Victor Matheu, MD, PhD, Department of Allergy, Hospital Universitario de Canarias, La Laguna, Spain E-mail Address: [email protected]Department of Allergy, Hospital Universitario de Canarias, La Laguna, Spain.Search for more papers by this author, Ruperto González-PérezDepartment of Allergy, Hospital Universitario de Canarias, La Laguna, Spain.Search for more papers by this author, Paloma Poza-GuedesDepartment of Allergy, Hospital Universitario de Canarias, La Laguna, Spain.Search for more papers by this author, Cristina Álava-CruzDepartment of Allergy, Hospital Universitario de Canarias, La Laguna, Spain.Search for more papers by this author, Elena Mederos LuísDepartment of Allergy, Hospital Universitario de Canarias, La Laguna, Spain.Search for more papers by this author, Inmaculada Sánchez-MachínDepartment of Allergy, Hospital Universitario de Canarias, La Laguna, Spain.Search for more papers by this author, Andres FrancoDepartment of Immunology, Hospital Universitario de Canarias, La Laguna, Spain.Search for more papers by this author, and Yvelise BarriosDepartment of Immunology, Hospital Universitario de Canarias, La Laguna, Spain.Search for more papers by this authorPublished Online:7 Dec 2020https://doi.org/10.1089/tmj.2020.0240AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail Dear EditorIn a recent communication to this journal, Ahn et al. indicated how individual or organizational users differentially use their Twitter® (Twitter, Inc., San Francisco, CA) accounts.1 We believe that these differences may also be influenced according to the type of patient group and the circumstances of the study period.Primary immunodeficiency disorders (PIDDs) are a wide group of diseases that are classified as rare diseases in Europe and characterized by poor or absent function in one or more components of the immune system that predisposes affected individuals to increased frequency and severity of infection. This increased vulnerability to infection may include repeated infections, infections that will not resolve, and sometimes severe or fatal infections.At the start of the SARS-Cov-2 pandemic, recommendations by the panel of medical advisers of the Spanish Association of Primary Immune Deficits (AEDIP) were issued.2 The coordination of the recently created primary immunodeficiency (PID) study group of our hospital3 decided that all adult patients of the PID module were contacted at least once by telephone,4 although few of them were contacted by other means (e-mail or WhatsApp® [WhatsApp Inc., Menlo Park, CA]). Of the 170 adult patients who until then had been assessed in the module, the clinical histories of 127 susceptible patients to close monitoring were evaluated. All of them were informed to follow the recommendations for confinement issued by the health authorities. Of these 127 patients, 62 patients were considered especially sensitive/critical, either due to their diagnosis of PID, mainly with immunoglobulin (Ig) deficit such as common variable immunodeficiency (CVID), specific antibody deficit, X-linked agammaglobulinemia, symptomatic selective IgA deficit, subclasses IgG deficit, or some of them with secondary ID—not HIV—or their inconclusive diagnosis but with figures IgG <450 mg/dL.Nine patients who continue treatment with intravenous Igs in the Daycare Hospital were given specific instructions and they were evaluated in each session. Fifty-one other patients who were (1) undergoing treatment with subcutaneous immune globulins at home or (2) with antibiotic treatment, or (3) without treatment but with an expectant attitude were provided with a direct communication media with the PID module and follow-up by phone at least every second week.More than 100 communications through telephone were made during those first weeks. In total, 141 interactions were made through Facebook® (Facebook, Inc., Menlo Park, CA), 337 interactions through Twitter, 24 by e-mail, or 131 interactions through WhatsApp were made. During these 98 days of alarm in Spain, all planned ongoing studies were not postponed, as they could be quoted electronically. A new patient was diagnosed with CVID with a diagnosis made in record time for our usual standards. Only two patients with PID had mild symptoms that could be compatible with SARS-Cov2 infection, but were negative.In the COVID-19 era, e-health has had a great impulse trying to avoid face-to-face assistance without having to reduce its attendance and quality.5 For adult patients with PID, initial follow-up consultations during this time have been made by telephone by their usual physician. As in other rare diseases, many patients have taken years to get a correct diagnosis and have gone through multiple doctors. Thus, we considered critical to hear the voice of their regular doctor in this time of uncertainty—COVID-19. We have made our patient social networks (website, Facebook, Twitter, and WhatsApp) available to them, and a specific e-mail account was previously created.6 These networks help to generate confidence from this kind of patients, who could hardly accept treatment and standards if they did not have trust in the professional group that cares for them. However, the initiatives have all come up individually by the responsible doctors. It would have been good to have a strategy at the hospital level or at the regional health service level instead of decisions by the hospital services or consultations.1 In the near future, and for the next waves of this COVID-19 pandemic, health services should have innovation units with a rapid capacity to respond to exceptional situations.The special susceptibility of these patients and the initial lack of knowledge about COVID-19 made us take these actions before the declaration of alarm. There were some initial drawbacks (wrong phone numbers, location outside the usual territory, etc.) that made the approach somewhat complicated. One of the causes of these problems has been the existing fragmentation of the territory of our Atlantic islands, separated from the European continent and that depend on air, sea, and land means for the transport of patients and also of materials. But information through alternative information channels adequately complemented these initial doubts. The public utility of social media stands out particularly in crisis. In our small population with rare diseases such as PIDDs, those media particularly Facebook and Twitter have been of mutual help.Now, 14 weeks later, we have opted to continue with conventional follow-ups. However, the possibility of a new wave of COVID-19 in next months, especially next autumn, makes us have new challenges to develop, such as optimizing communication channels and designing “free assistance circuits,” on different days of consultation with little influx of patients, and perhaps, create an innovative, permanent, and reliable structure for alternative communication with patients according to the standards of the 21st century.Disclosure StatementNo competing financial interests exist.References1. Ahn J, Jeon YA, Murthy D. Differences in health-related social media usage by organizations and individuals. Telemed J E Health 2020;26:812–820. Link, Google Scholar2. Español T, Seoane E. Recomendaciones Específicas Inmunodeficientes. Available at https://www.aedip.com/wp-content/uploads/2020/03/actualizacion-coronavirus.pdf (last accessed March 5, 2020). Google Scholar3. Barrios Y, Franco A, Alonso-Larruga A, Sánchez-Machín I, Poza-Guedes P, Gonzalez R, et al. Multidisciplinary team work to succeed: A primary immunodeficiency unit experience. J Investig Allergol Clin Immunol 2020;30:208–210. Crossref, Medline, Google Scholar4. Alvarez-Perea A, Sánchez-García S, Muñoz Cano R, Antolín-Amérigo D, Tsilochristou O, Stukus DR. Impact of “eHealth” in allergic diseases and allergic patients. J Investig Allergol Clin Immunol 2019;29:94–102. Crossref, Medline, Google Scholar5. González-Pérez R, Sánchez-Machín I, Poza-Guedes P, Matheu V, Álava-Cruz C, Mederos Luís E. Pertinence of telehealth in a rush conversion to virtual allergy practice during the COVID-19 outbreak. J Investig Allergol Clin Immunol 2020. DOI: 10.18176/jiaci.0597 Crossref, Medline, Google Scholar6. Sanchez-Machin I, Poza-Guedes P, Gonzalez-Perez R, Matheu V. Experience in the use of social media (WhatsApp, e-mail, Facebook, website) By patients. J Allergy Clin Immunol 2015;135(2 suppl):AB135. Crossref, Google ScholarFiguresReferencesRelatedDetailsCited byAccounting information quality detection method of listed companies based on mobile social network interaction modelJournal of Computational Methods in Sciences and Engineering, Vol. 22, No. 3Implementing information and communication technology education on food allergy and anaphylaxis in the school setting3 July 2021 | Clinical and Translational Allergy, Vol. 11, No. 5Clinical management of patients with primary immunodeficiencies during the COVID-19 pandemic15 January 2021 | Expert Review of Clinical Immunology, Vol. 17, No. 2 Volume 26Issue 12Dec 2020 InformationCopyright 2020, Mary Ann Liebert, Inc., publishersTo cite this article:Victor Matheu, Ruperto González-Pérez, Paloma Poza-Guedes, Cristina Álava-Cruz, Elena Mederos Luís, Inmaculada Sánchez-Machín, Andres Franco, and Yvelise Barrios.Letter to the Editor: Support Through Social Networks of e-Health in Adults with Primary Immunodeficiencies During COVID-19 Pandemic.Telemedicine and e-Health.Dec 2020.1438-1439.http://doi.org/10.1089/tmj.2020.0240Published in Volume: 26 Issue 12: December 7, 2020Online Ahead of Print:July 1, 2020PDF download" @default.
• W3038823489 created "2020-07-10" @default.
• W3038823489 creator A5013739626 @default.
• W3038823489 creator A5018408523 @default.
• W3038823489 creator A5036240035 @default.
• W3038823489 creator A5047843334 @default.
• W3038823489 creator A5072414220 @default.
• W3038823489 creator A5081168398 @default.
• W3038823489 creator A5087703458 @default.
• W3038823489 creator A5088725427 @default.
• W3038823489 date "2020-12-01" @default.
• W3038823489 modified "2023-10-11" @default.
• W3038823489 title "<i>Letter to the Editor:</i> Support Through Social Networks of e-Health in Adults with Primary Immunodeficiencies During COVID-19 Pandemic" @default.
• W3038823489 cites W2069339901 @default.
• W3038823489 cites W2901465909 @default.
• W3038823489 cites W2972817227 @default.
• W3038823489 cites W3000310241 @default.
• W3038823489 cites W3033733420 @default.
• W3038823489 doi "https://doi.org/10.1089/tmj.2020.0240" @default.
• W3038823489 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32614690" @default.
• W3038823489 hasPublicationYear "2020" @default.
• W3038823489 type Work @default.
• W3038823489 sameAs 3038823489 @default.
• W3038823489 citedByCount "3" @default.
• W3038823489 countsByYear W30388234892021 @default.
• W3038823489 crossrefType "journal-article" @default.
• W3038823489 hasAuthorship W3038823489A5013739626 @default.
• W3038823489 hasAuthorship W3038823489A5018408523 @default.
• W3038823489 hasAuthorship W3038823489A5036240035 @default.
• W3038823489 hasAuthorship W3038823489A5047843334 @default.
• W3038823489 hasAuthorship W3038823489A5072414220 @default.
• W3038823489 hasAuthorship W3038823489A5081168398 @default.
• W3038823489 hasAuthorship W3038823489A5087703458 @default.
• W3038823489 hasAuthorship W3038823489A5088725427 @default.
• W3038823489 hasConcept C116675565 @default.
• W3038823489 hasConcept C126322002 @default.
• W3038823489 hasConcept C159047783 @default.
• W3038823489 hasConcept C2779134260 @default.
• W3038823489 hasConcept C3006700255 @default.
• W3038823489 hasConcept C3007834351 @default.
• W3038823489 hasConcept C3008058167 @default.
• W3038823489 hasConcept C524204448 @default.
• W3038823489 hasConcept C71924100 @default.
• W3038823489 hasConcept C89623803 @default.
• W3038823489 hasConceptScore W3038823489C116675565 @default.
• W3038823489 hasConceptScore W3038823489C126322002 @default.
• W3038823489 hasConceptScore W3038823489C159047783 @default.
• W3038823489 hasConceptScore W3038823489C2779134260 @default.
• W3038823489 hasConceptScore W3038823489C3006700255 @default.
• W3038823489 hasConceptScore W3038823489C3007834351 @default.
• W3038823489 hasConceptScore W3038823489C3008058167 @default.
• W3038823489 hasConceptScore W3038823489C524204448 @default.
• W3038823489 hasConceptScore W3038823489C71924100 @default.
• W3038823489 hasConceptScore W3038823489C89623803 @default.
• W3038823489 hasIssue "12" @default.
• W3038823489 hasLocation W30388234891 @default.
• W3038823489 hasOpenAccess W3038823489 @default.
• W3038823489 hasPrimaryLocation W30388234891 @default.
• W3038823489 hasRelatedWork W3017171836 @default.
• W3038823489 hasRelatedWork W3025176011 @default.
• W3038823489 hasRelatedWork W3027835066 @default.
• W3038823489 hasRelatedWork W3032320397 @default.
• W3038823489 hasRelatedWork W3033635008 @default.
• W3038823489 hasRelatedWork W3152606407 @default.
• W3038823489 hasRelatedWork W4280491013 @default.
• W3038823489 hasRelatedWork W4308017287 @default.
• W3038823489 hasRelatedWork W3107152225 @default.
• W3038823489 hasRelatedWork W3183300108 @default.
• W3038823489 hasVolume "26" @default.
• W3038823489 isParatext "false" @default.
• W3038823489 isRetracted "false" @default.
• W3038823489 magId "3038823489" @default.
• W3038823489 workType "article" @default.